China's scientific publications in Immunology and Microbiology have demonstrated substantial growth from 2013 to 2023, increasing from 4,120 to 12,090 publications. Notably, the past two years, 2022 and 2023, saw year-on-year variations of 9.98% and 9.03%, respectively. Furthermore, the Compound Annual Growth Rate (CAGR) for the last five years stands at 12.51%, indicating sustained momentum in research outputs.

Looking forward, the forecast from 2024 to 2028 predicts a continued upward trajectory, with an anticipated CAGR of 5.31% over the next five years. This is expected to result in a total growth rate of 29.55% by 2028, reaching approximately 16,940 publications.

Future trends to watch include:

Potential impact of government funding on research initiatives.
The influence of global collaborations and partnerships on publication volumes.
Technological advancements in research facilities and methodologies.
Addressing emerging health challenges and pandemics which may drive a surge in relevant research publications.